Literature DB >> 15880273

Ventricular arrhythmia following short-acting nifedipine administration.

M Patricia Castaneda1, Christine A Walsh, Robert P Woroniecki, Marcela Del Rio, Joseph T Flynn.   

Abstract

Short-acting nifedipine is still advocated for use in children with severe hypertension, but is no longer recommended for use in adults because of adverse effects from rapid blood pressure reduction. A 19 year-old adolescent with symptomatic, severe hypertension (blood pressure 180/120) received 10 mg of short-acting nifedipine sublingually for blood pressure reduction. Within minutes after the dose, the patient complained of palpitations. Tachycardia (heart rate 100 beats per minute) and bigeminy were noted on the cardiac monitor. The bigeminy resolved but premature ventricular contractions were noted for the duration of her hospital stay. We hypothesize that reflex sympathetic activation following an abrupt drop in blood pressure may cause arrhythmias because of elevated catecholamine levels. Given this, it may be more appropriate to treat severe hypertension in children with intravenous antihypertensive agents that can be titrated to produce controlled reductions in blood pressure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15880273     DOI: 10.1007/s00467-005-1854-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  16 in total

1.  Adverse neurologic events associated with rebound hypertension after using short-acting nifedipine in childhood hypertension.

Authors:  M B Leonard; S E Kasner; H I Feldman; S L Schulman
Journal:  Pediatr Emerg Care       Date:  2001-12       Impact factor: 1.454

2.  Short-acting nifedipine.

Authors:  B Gauthier; H Trachtman
Journal:  Pediatr Nephrol       Date:  1997-12       Impact factor: 3.714

3.  Symptomatic hypotension induced by nifedipine in the acute treatment of severe hypertension.

Authors:  R M Wachter
Journal:  Arch Intern Med       Date:  1987-03

4.  Evaluation of the safety of short-acting nifedipine in children with hypertension.

Authors:  David W Egger; Douglas D Deming; Norman Hamada; Ronald M Perkin; Shobha Sahney
Journal:  Pediatr Nephrol       Date:  2002-01       Impact factor: 3.714

Review 5.  Calcium channel blockers: pharmacology and place in therapy of pediatric hypertension.

Authors:  J T Flynn; D A Pasko
Journal:  Pediatr Nephrol       Date:  2000-12       Impact factor: 3.714

Review 6.  Ventricular arrhythmias in normal hearts.

Authors:  B B Lerman; K M Stein; S M Markowitz; S Mittal; D J Slotwiner
Journal:  Cardiol Clin       Date:  2000-05       Impact factor: 2.213

7.  Fatal nifedipine ingestions in children.

Authors:  D C Lee; T Greene; T Dougherty; P Pearigen
Journal:  J Emerg Med       Date:  2000-11       Impact factor: 1.484

8.  Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure.

Authors:  E Grossman; F H Messerli
Journal:  Am J Cardiol       Date:  1997-12-01       Impact factor: 2.778

9.  The use of short-acting nifedipine in pediatric patients with hypertension.

Authors:  R T Blaszak; J A Savage; E N Ellis
Journal:  J Pediatr       Date:  2001-07       Impact factor: 4.406

10.  The risk of myocardial infarction associated with antihypertensive drug therapies.

Authors:  B M Psaty; S R Heckbert; T D Koepsell; D S Siscovick; T E Raghunathan; N S Weiss; F R Rosendaal; R N Lemaitre; N L Smith; P W Wahl
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272

View more
  5 in total

Review 1.  Hypertensive crisis in children.

Authors:  Jayanthi Chandar; Gastón Zilleruelo
Journal:  Pediatr Nephrol       Date:  2011-07-20       Impact factor: 3.714

Review 2.  The management of hypertensive emergencies in children after stem cell transplantation.

Authors:  D G Horn; M N Trame; G Hempel
Journal:  Int J Clin Pharm       Date:  2011-03-12

Review 3.  Therapy of acute hypertension in hospitalized children and adolescents.

Authors:  Tennille N Webb; Ibrahim F Shatat; Yosuke Miyashita
Journal:  Curr Hypertens Rep       Date:  2014-04       Impact factor: 5.369

4.  Isradipine for treatment of acute hypertension in hospitalized children and adolescents.

Authors:  Yosuke Miyashita; Do Peterson; Jane M Rees; Joseph T Flynn
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-11       Impact factor: 3.738

Review 5.  Antihypertensive agents: a long way to safe drug prescribing in children.

Authors:  Nida Siddiqi; Ibrahim F Shatat
Journal:  Pediatr Nephrol       Date:  2019-11-01       Impact factor: 3.651

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.